Insider Trading February 6, 2026 03:28 PM

Roper Director Adds $501,844 in Stock; Company Posts Mixed Q4 2025 Results

Director Joyce Thomas Patrick Jr. acquired 1,400 shares on Feb. 6, 2026 as Roper reported EPS above estimates but revenue slightly below forecasts

By Hana Yamamoto ROP

Joyce Thomas Patrick Jr., a director at Roper Technologies, purchased 1,400 shares of the company's common stock on February 6, 2026, in trades totaling $501,844. The purchases were executed at prices between $358.34 and $358.50, with an average execution price reported as $358.46. After the transactions, Patrick directly holds 3,775 Roper shares while the 1,400-share lot is held indirectly in a Spousal Trust. Separately, Roper Technologies reported fourth-quarter 2025 results with adjusted earnings per share of $5.21 versus expectations of $5.14, while revenue of $2.06 billion trailed the $2.08 billion analysts had forecast.

Roper Director Adds $501,844 in Stock; Company Posts Mixed Q4 2025 Results
ROP

Key Points

  • Joyce Thomas Patrick Jr. purchased 1,400 shares of Roper Technologies on February 6, 2026 for a total of $501,844, executed across multiple trades priced between $358.34 and $358.50.
  • After the transaction, Patrick directly holds 3,775 shares of Roper and the 1,400 shares are held indirectly in a Spousal Trust.
  • Roper Technologies reported Q4 2025 EPS of $5.21, beating the $5.14 expectation, while revenue was $2.06 billion, slightly under the $2.08 billion forecast - a mixed set of results for investors and markets.

Transaction details

On February 6, 2026, Roper Technologies director Joyce Thomas Patrick Jr. acquired 1,400 shares of the company's common stock. The transaction amounted to $501,844 and was carried out in multiple trades at prices ranging from $358.34 to $358.50, with a reported unit price of $358.46. Following these purchases, Patrick directly owns 3,775 shares of Roper. The block of 1,400 shares is held indirectly in a Spousal Trust.


Company financials for the quarter

Roper Technologies released its fourth-quarter 2025 results showing a mixed performance versus market expectations. The company delivered earnings per share of $5.21, outpacing the consensus forecast of $5.14. Revenue in the quarter totaled $2.06 billion, which was slightly below the $2.08 billion that analysts had been expecting.


Context and market signals

The insider purchase is factual and specific in size and timing. At the same time, the company’s latest quarterly report contained both a positive earnings surprise and a modest revenue shortfall. These dual outcomes - insider buying and mixed quarterly results - provide concrete datapoints for investors assessing near-term company performance and management actions.


What is known and what remains limited

This report contains the completed trade details and the headline quarterly financial figures as released. It does not provide additional information on the motivations behind the purchase, any planned future transactions, nor further breakdowns of the quarterly earnings and revenue drivers beyond the summary totals cited above.


Implications for market participants

Investors and market observers can register the director purchase alongside the company’s mixed earnings report when forming views on Roper’s near-term prospects. The purchase value and the differential between EPS and revenue relative to expectations are clear data points; however, this account does not extend to conclusions about long-term outlook or valuation beyond the figures and holdings reported.

Risks

  • Revenue for Q4 2025 was modestly below analyst forecasts, presenting near-term revenue execution risk that may concern investors and equity market participants.
  • The report does not disclose the director’s rationale for the purchase or any future trading intentions, leaving uncertainty about whether the transaction signals a sustained insider buying trend.
  • Available information is limited to headline figures and shareholding changes - further operational detail and segment-level drivers are not provided, constraining deeper assessment of financial performance.

More from Insider Trading

Spero Therapeutics Executive Executes Automatic Stock Sale Amid Strong Financial Turnaround May 6, 2026 Natera Executive Chairman Executes $1.64 Million in Stock Dispositions May 6, 2026 Insider Activity Detected at Rallybio Corp Following Substantial Share Acquisitions May 6, 2026 A10 Networks Director Eric Singer Executes Stock Sale Amidst Recent Earnings Strength May 6, 2026 Delek US Holdings Director Ezra Uzi Yemin Executes $1.6 Million Stock Sale May 6, 2026